HEADER OXIDOREDUCTASE 11-JAN-22 7QRI TITLE REGULATORY DOMAIN DIMER OF TRYPTOPHAN HYDROXYLASE 2 IN COMPLEX WITH L- TITLE 2 PHE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPTOPHAN 5-HYDROXYLASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NEURONAL TRYPTOPHAN HYDROXYLASE,TRYPTOPHAN 5-MONOOXYGENASE COMPND 5 2; COMPND 6 EC: 1.14.16.4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TPH2, NTPH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS TRYPTOPHAN HYDROXYLASE 2, SEROTONIN BIOSYNTHESIS, AROMATIC AMINO ACID KEYWDS 2 HYDROXYLASE, OXIDOREDUCTASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR I.M.VEDEL,A.PRESTEL,P.HARRIS,G.H.J.PETERS,B.B.KRAGELUND REVDAT 4 19-JUN-24 7QRI 1 REMARK REVDAT 3 14-JUN-23 7QRI 1 JRNL REVDAT 2 10-MAY-23 7QRI 1 JRNL REVDAT 1 03-MAY-23 7QRI 0 JRNL AUTH I.M.VEDEL,A.PRESTEL,Z.ZHANG,N.T.SKAWINSKA,H.STARK,P.HARRIS, JRNL AUTH 2 B.B.KRAGELUND,G.H.J.PETERS JRNL TITL STRUCTURAL CHARACTERIZATION OF HUMAN TRYPTOPHAN HYDROXYLASE JRNL TITL 2 2 REVEALS THAT L-PHE IS SUPERIOR TO L-TRP AS THE REGULATORY JRNL TITL 3 DOMAIN LIGAND. JRNL REF STRUCTURE V. 31 689 2023 JRNL REFN ISSN 0969-2126 JRNL PMID 37119821 JRNL DOI 10.1016/J.STR.2023.04.004 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.44 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7QRI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1292119568. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 0.344 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.1 MM [U-99% 13C; U-99% 15N] REMARK 210 TRYPTOPHAN HYDROXYLASE 2 (GP+ 48 REMARK 210 TO 145), 10 MM L-PHE, 20 MM REMARK 210 SODIUM PHOSPHATE, 100 MM REMARK 210 AMMONIUM SULFATE, 125 UM DSS, 95% REMARK 210 H2O/5% D2O; 0.45 MM TRYPTOPHAN REMARK 210 HYDROXYLASE 2 (GP+ 48 TO 145), REMARK 210 2.6 MM [U-13C; U-15N] L-PHE, 20 REMARK 210 MM SODIUM PHOSPHATE, 100 MM REMARK 210 AMMONIUM SULFATE, 125 UM DSS, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 HN(COCA)CB; 3D HNCO; 3D HN(CA)CO; REMARK 210 2D 1H-13C HSQC ALIPHATIC; 2D 1H- REMARK 210 13C HSQC AROMATIC; 3D 1H-13C REMARK 210 NOESY ALIPHATIC; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY ALIPHATIC 13C/ REMARK 210 15N FILTERED; 3D 1H-15N NOESY REMARK 210 13C/15N FILTERED; 3D HCCH-TOCSY; REMARK 210 2D 1H-13C HSQC ALIPHATIC AMINO REMARK 210 ACID SPECIFIC REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.98.5, CCPNMR ANALYSIS REMARK 210 2.4.2, NMRPIPE, TOPSPIN 3.5, REMARK 210 QMDD, TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 136 72.16 50.44 REMARK 500 1 LYS B 50 -142.81 69.55 REMARK 500 1 GLU B 60 -138.18 60.90 REMARK 500 2 THR A 59 71.69 65.27 REMARK 500 2 ARG A 101 -114.60 68.98 REMARK 500 2 ILE A 141 -62.82 77.84 REMARK 500 2 ALA B 57 50.61 -152.96 REMARK 500 2 ARG B 101 -114.53 69.05 REMARK 500 3 SER A 52 -157.64 72.93 REMARK 500 3 LEU A 135 -58.10 70.31 REMARK 500 3 SER B 53 -107.28 66.84 REMARK 500 3 LEU B 135 -64.07 69.67 REMARK 500 3 ASN B 140 42.11 -86.67 REMARK 500 3 GLU B 144 69.56 -107.47 REMARK 500 4 ARG A 100 -153.84 59.13 REMARK 500 4 LYS B 54 -163.37 74.38 REMARK 500 4 ARG B 100 -153.92 59.07 REMARK 500 4 LEU B 135 -65.48 74.78 REMARK 500 5 ARG A 101 -116.58 65.91 REMARK 500 5 ASN A 136 136.14 74.41 REMARK 500 5 ARG B 101 -116.48 65.91 REMARK 500 5 ASN B 136 78.16 54.48 REMARK 500 5 ILE B 141 84.37 61.11 REMARK 500 6 LYS A 50 -119.54 62.52 REMARK 500 6 ALA A 58 160.49 84.25 REMARK 500 6 ARG A 102 71.34 68.79 REMARK 500 6 ASN A 136 74.06 63.04 REMARK 500 6 ILE A 141 68.65 62.31 REMARK 500 6 SER B 61 -63.72 -161.53 REMARK 500 6 ARG B 102 71.37 68.64 REMARK 500 7 GLU A 60 31.87 -144.75 REMARK 500 7 ILE A 141 -63.38 75.77 REMARK 500 7 ASN B 49 -81.76 -161.24 REMARK 500 7 ASN B 136 71.57 79.90 REMARK 500 8 ASN A 72 49.16 -78.30 REMARK 500 8 ARG A 101 -80.31 -160.94 REMARK 500 8 ASN A 140 38.38 -96.54 REMARK 500 8 GLU B 60 -130.83 62.72 REMARK 500 8 SER B 61 -77.26 -164.72 REMARK 500 8 ASN B 72 49.50 -78.23 REMARK 500 8 ARG B 101 -80.30 -160.93 REMARK 500 9 ASN A 49 -117.79 64.30 REMARK 500 9 ALA A 57 41.15 -158.13 REMARK 500 9 ASN A 140 40.57 -88.57 REMARK 500 9 LYS B 50 69.08 66.81 REMARK 500 9 GLU B 56 -66.14 -144.86 REMARK 500 9 ALA B 57 -44.77 -172.90 REMARK 500 9 ASN B 136 -59.35 -165.25 REMARK 500 10 GLU A 60 -144.21 63.31 REMARK 500 10 LEU A 135 -71.92 72.42 REMARK 500 REMARK 500 THIS ENTRY HAS 134 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34698 RELATED DB: BMRB REMARK 900 REGULATORY DOMAIN DIMER OF TRYPTOPHAN HYDROXYLASE 2 IN COMPLEX WITH REMARK 900 L-PHE DBREF 7QRI A 48 145 UNP Q8IWU9 TPH2_HUMAN 48 145 DBREF 7QRI B 48 145 UNP Q8IWU9 TPH2_HUMAN 48 145 SEQADV 7QRI GLY A 46 UNP Q8IWU9 EXPRESSION TAG SEQADV 7QRI PRO A 47 UNP Q8IWU9 EXPRESSION TAG SEQADV 7QRI GLY B 46 UNP Q8IWU9 EXPRESSION TAG SEQADV 7QRI PRO B 47 UNP Q8IWU9 EXPRESSION TAG SEQRES 1 A 100 GLY PRO GLY ASN LYS GLY SER SER LYS ARG GLU ALA ALA SEQRES 2 A 100 THR GLU SER GLY LYS THR ALA VAL VAL PHE SER LEU LYS SEQRES 3 A 100 ASN GLU VAL GLY GLY LEU VAL LYS ALA LEU ARG LEU PHE SEQRES 4 A 100 GLN GLU LYS ARG VAL ASN MET VAL HIS ILE GLU SER ARG SEQRES 5 A 100 LYS SER ARG ARG ARG SER SER GLU VAL GLU ILE PHE VAL SEQRES 6 A 100 ASP CYS GLU CYS GLY LYS THR GLU PHE ASN GLU LEU ILE SEQRES 7 A 100 GLN LEU LEU LYS PHE GLN THR THR ILE VAL THR LEU ASN SEQRES 8 A 100 PRO PRO GLU ASN ILE TRP THR GLU GLU SEQRES 1 B 100 GLY PRO GLY ASN LYS GLY SER SER LYS ARG GLU ALA ALA SEQRES 2 B 100 THR GLU SER GLY LYS THR ALA VAL VAL PHE SER LEU LYS SEQRES 3 B 100 ASN GLU VAL GLY GLY LEU VAL LYS ALA LEU ARG LEU PHE SEQRES 4 B 100 GLN GLU LYS ARG VAL ASN MET VAL HIS ILE GLU SER ARG SEQRES 5 B 100 LYS SER ARG ARG ARG SER SER GLU VAL GLU ILE PHE VAL SEQRES 6 B 100 ASP CYS GLU CYS GLY LYS THR GLU PHE ASN GLU LEU ILE SEQRES 7 B 100 GLN LEU LEU LYS PHE GLN THR THR ILE VAL THR LEU ASN SEQRES 8 B 100 PRO PRO GLU ASN ILE TRP THR GLU GLU HET PHE A 201 23 HET PHE B 201 23 HETNAM PHE PHENYLALANINE FORMUL 3 PHE 2(C9 H11 N O2) HELIX 1 AA1 GLY A 75 LYS A 87 1 13 HELIX 2 AA2 GLY A 115 THR A 130 1 16 HELIX 3 AA3 GLY B 75 LYS B 87 1 13 HELIX 4 AA4 GLY B 115 THR B 130 1 16 SHEET 1 AA1 3 THR A 64 LYS A 71 0 SHEET 2 AA1 3 GLU A 105 CYS A 112 -1 O ILE A 108 N PHE A 68 SHEET 3 AA1 3 MET A 91 ARG A 97 -1 N GLU A 95 O PHE A 109 SHEET 1 AA2 3 THR B 64 LYS B 71 0 SHEET 2 AA2 3 GLU B 105 CYS B 112 -1 O ILE B 108 N PHE B 68 SHEET 3 AA2 3 MET B 91 ARG B 97 -1 N GLU B 95 O PHE B 109 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1